Kenyan government must review law on counterfeit drugs, High Court rules

"Kenya's High Court ruled on Friday that lawmakers must review legislation that could threaten the import of generic drugs, allowing Kenyans to continue accessing affordable medicine," Reuters reports. In 2009, three people living with HIV filed a lawsuit arguing that the definition of counterfeit drugs in Kenya's Anti-Counterfeit Bill of 2008 was too broad and "unconstitutional because it threatened access to life-saving generic medicine by confusing generic and fake medicine," the news agency notes (4/20).

"The ruling means that the government must amend the laws that confuse generic medicines with counterfeits and remove ambiguities that may result in arbitrary seizures of generic medicines under the guise of fighting counterfeits," Capital FM reports (Jillo, 4/20). In a press statement, UNAIDS Executive Director Michel Sidibe said, "A vast majority of people in Kenya rely on quality generic drugs for their daily survival. Through this important ruling, the High Court of Kenya has upheld a fundamental element of the right to health. ... This decision will set an important precedent for ensuring access to lifesaving drugs around the world," according to the U.N. News Centre (4/20).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation